Suppr超能文献

采用质谱法分析低分子量肝素中的硫酸盐:依诺肝素的结构特征。

Analysis of sulfates on low molecular weight heparin using mass spectrometry: structural characterization of enoxaparin.

机构信息

a Department of Biochemistry and Molecular Biology , University of Nebraska Medical Center , Omaha , Nebraska , USA.

b Eppley Institute for Research in Cancer and Allied Diseases and Buffett Cancer Center , University of Nebraska Medical Center , Omaha , Nebraska , USA.

出版信息

Expert Rev Proteomics. 2018 Jun;15(6):503-513. doi: 10.1080/14789450.2018.1480110. Epub 2018 May 31.

Abstract

Structural characterization of low molecular weight heparin (LMWH) is critical to meet biosimilarity standards. In this context, the review focuses on structural analysis of labile sulfates attached to the side-groups of LMWH using mass spectrometry. A comprehensive review of this topic will help readers to identify key strategies for tackling the problem related to sulfate loss. At the same time, various mass spectrometry techniques are presented to facilitate compositional analysis of LMWH, mainly enoxaparin. Areas covered: This review summarizes findings on mass spectrometry application for LMWH, including modulation of sulfates, using enzymology and sample preparation approaches. Furthermore, popular open-source software packages for automated spectral data interpretation are also discussed. Successful use of LC/MS can decipher structural composition for LMWH and help evaluate their sameness or biosimilarity with the innovator molecule. Overall, the literature has been searched using PubMed by typing various search queries such as 'enoxaparin', 'mass spectrometry', 'low molecular weight heparin', 'structural characterization', etc. Expert commentary: This section highlights clinically relevant areas that need improvement to achieve satisfactory commercialization of LMWHs. It also primarily emphasizes the advancements in instrumentation related to mass spectrometry, and discusses building automated software for data interpretation and analysis.

摘要

结构表征对满足低分子肝素(LMWH)的生物相似性标准至关重要。在这方面,本综述重点关注使用质谱法对 LMWH 侧链上不稳定硫酸酯进行的结构分析。对这一主题的全面回顾将帮助读者确定解决与硫酸酯丢失相关问题的关键策略。同时,还介绍了各种质谱技术,以促进 LMWH(主要是依诺肝素)的组成分析。

涵盖领域

本综述总结了用于 LMWH 的质谱应用的发现,包括使用酶学和样品制备方法对硫酸酯进行调制。此外,还讨论了用于自动光谱数据分析的流行开源软件包。成功使用 LC/MS 可以解析 LMWH 的结构组成,并有助于评估其与创新分子的相同性或生物相似性。总体而言,使用 PubMed 搜索文献,输入各种搜索查询,如“依诺肝素”、“质谱”、“低分子肝素”、“结构表征”等。

专家评论

本节重点介绍了需要改进的临床相关领域,以实现 LMWH 的满意商业化。它还主要强调了与质谱相关的仪器设备的进步,并讨论了用于数据解释和分析的自动化软件的构建。

相似文献

1
Analysis of sulfates on low molecular weight heparin using mass spectrometry: structural characterization of enoxaparin.
Expert Rev Proteomics. 2018 Jun;15(6):503-513. doi: 10.1080/14789450.2018.1480110. Epub 2018 May 31.
2
3
Glycan Mapping of Low-Molecular-Weight Heparin Using Mass Spectral Correction Based on Chromatography Fitting with "Glycomapping" Software.
Anal Chem. 2022 Sep 27;94(38):13000-13009. doi: 10.1021/acs.analchem.2c01579. Epub 2022 Sep 14.
4
Liquid chromatography-diode array detection-mass spectrometry for compositional analysis of low molecular weight heparins.
Anal Biochem. 2014 Apr 15;451:35-41. doi: 10.1016/j.ab.2014.02.005. Epub 2014 Feb 14.
6
Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragments.
Anal Bioanal Chem. 2014 Jan;406(1):249-65. doi: 10.1007/s00216-013-7446-4. Epub 2013 Nov 20.
8
Susceptibility of enoxaparin reducing end amino sugars to periodate oxidation.
Carbohydr Res. 2014 Dec 5;400:33-43. doi: 10.1016/j.carres.2014.08.016. Epub 2014 Sep 10.
10
Reversed-phase ion-pair ultra-high-performance-liquid chromatography-mass spectrometry for fingerprinting low-molecular-weight heparins.
J Chromatogr A. 2013 May 31;1292:201-10. doi: 10.1016/j.chroma.2013.01.011. Epub 2013 Jan 10.

引用本文的文献

2
Antiviral efficacy of heparan sulfate and enoxaparin sodium against SARS-CoV-2.
Arch Pharm (Weinheim). 2025 Jan;358(1):e2400545. doi: 10.1002/ardp.202400545. Epub 2024 Nov 9.
3
Biomedical applications of engineered heparin-based materials.
Bioact Mater. 2023 Aug 10;31:87-118. doi: 10.1016/j.bioactmat.2023.08.002. eCollection 2024 Jan.
4
Molecular Mechanism of the Anti-Inflammatory Action of Heparin.
Int J Mol Sci. 2021 Oct 3;22(19):10730. doi: 10.3390/ijms221910730.
5
Release characteristics of enoxaparin sodium-loaded polymethylmethacrylate bone cement.
J Orthop Surg Res. 2021 Feb 4;16(1):108. doi: 10.1186/s13018-021-02223-w.
7
Biosimilars of low molecular weight heparins: Relevant background information for your drug formulary.
Br J Clin Pharmacol. 2019 Nov;85(11):2479-2486. doi: 10.1111/bcp.14081. Epub 2019 Sep 4.

本文引用的文献

3
Comparison of the effectiveness of venous thromboembolism prophylaxis with enoxaparin between obese and non-obese patients.
J Oncol Pharm Pract. 2019 Jun;25(4):813-817. doi: 10.1177/1078155218760159. Epub 2018 Feb 28.
4
Heparin mimetics with anticoagulant activity.
Med Res Rev. 2018 Sep;38(5):1582-1613. doi: 10.1002/med.21489. Epub 2018 Feb 15.
5
Sequencing the oligosaccharide pool in the low molecular weight heparin dalteparin with offline HPLC and ESI-MS/MS.
Carbohydr Polym. 2018 Mar 1;183:81-90. doi: 10.1016/j.carbpol.2017.11.039. Epub 2017 Nov 13.
6
Antithrombin III-Binding Site Analysis of Low-Molecular-Weight Heparin Fractions.
J Pharm Sci. 2018 May;107(5):1290-1295. doi: 10.1016/j.xphs.2018.01.008. Epub 2018 Jan 12.
8
Prophylactic enoxaparin doses may be inadequate in patients undergoing abdominal cancer surgery.
J Surg Res. 2018 Jan;221:183-189. doi: 10.1016/j.jss.2017.08.053. Epub 2017 Sep 25.
9
Individual benefits of enoxaparin treatment in branch vein occlusion.
Graefes Arch Clin Exp Ophthalmol. 2018 May;256(5):1031-1033. doi: 10.1007/s00417-017-3854-z. Epub 2017 Dec 1.
10
Recent Developments in the Separation of Low Molecular Weight Heparin Anticoagulants.
Curr Med Chem. 2019;26(1):166-176. doi: 10.2174/0929867324666171005114150.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验